Additional Patent Protection for Melflufen Granted in the US Until 2033 – Benzinga

Additional Patent Protection for Melflufen Granted in the US Until 2033  Benzinga

STOCKHOLM, April 10, 2019 /PRNewswire/ — Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that the US patent and trademark office has …